Диагностическая значимость белка S100B при критических состояниях
https://doi.org/10.15360/1813-9779-2011-6-72
Аннотация
Список литературы
1. Moore B. W.
2. Whitelaw A., Rosengren L., Blennow M.Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch. Dis. Child Fetal Neonatal Ed. 2001; 84 (2): F90—F91.
3. Schafer B. W., Fritschy J. M., Murmann P. et al.Brain S100A5 is a novel calcium-zinc- and copper ion-binding protein of the EF-hand super-family. J. Biol. Chem. 2000; 275 (39): 30623—30630.
4. Rothoerl R. D., Brawanski A., Woertgen C.S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir. (Wien) 2001; 142 (2): 199—203.
5. Грудень М. А., Сторожева З. И., Шерстнев В. В.Регуляторные антитела к нейротрофическим факторам: клинико-экспериментальное исследование. В кн.: Нейроиммунопатология. М.: Медицина; 1999.
6. Donato R.S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001; 33 (7): 637—668.
7. Griffin S. W. T., Sheng J. G., Royston M. C. et al.Glia-neuronal interactions in Alzheimer’s disease: the potential role of a «cytokine cycle» in disease. Brain Pathol. 1998; 8 (1): 65—72.
8. Allore R., O Hanlon D., Price R. et al.Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science 1988; 239 (4845): 1311 — 1313.
9. Траилин А. В., Левада О. А.Белок S100В: нейробиология, значение при неврологической и психиатрической патологии. Междунар. неврол. журн. 2009; 1: 166—175.
10. Beer C., Blacker D., Bynevelt M. et al.Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke. J. Neuroinflammation 2010; 7: 71.
11. EltingJ. W., deJager A. E., Teelken A. W. et al.Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J. Neurol. Sci. 2000; 181 (1—2): 104—110.
12. Gazzolo D., Vinesi P., Bartocci M. et al.Elevated S100 blood level as early indicators of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J. Neurol. Sci. 1999; 170 (1): 32—35.
13. ГолоснаяГ. С., ПетрухинА. С., МаркевичК. А., ТрифоповаО. Е.Изменение уровня белка S-100 у новорожденных с перинатальным ги-поксическим поражением ЦНС. Педиатрия 2004; 1: 10—14.
14. Michetti F., Massaro A., Russo G., Rigon G.The S-100 antigen in cere-brospinal fluid as a possible index of cell injury in the nervous system. J. Neurol. Sci. 1980; 44 (2—3): 259—263.
15. Berger R. P., Pierce M. C., Wisniewski S. R. et al.Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002; 109 (2): E31.
16. Garnier Y., Frigiola A., Li Volti G.Increased maternal/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod. Sci. 2009; 16 (8): 758—766.
17. Blennow M., Savman K., lives P. et al.Brain-specific proteins in the cere-brospinal fluid of severely asphyxiated newborn infants. Acta Paediatr. 2001; 90 (10): 1171—1175.
18. Gazzolo D., Bruschettini M., Lituania M. et al.S100B proteins in urine are correlated with gestational age in healthy preterm and term new-borns. Clin. Chem. 2001; 47 (6): 1132—1133.
19. Reiber H.Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 2001; 310 (2): 173—186.
20. de Kruijk J. R., Leffers J. R., Menheere P. P. et al.S100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with healthy controls. Acta Neurol. Scand. 2001; 103 (3): 175—179.
21. Anderson R. E., Hansson L. O., Nilsson O. et al.High serum S100B levels from trauma patients without head injuries. Neurosurgery 2001; 48 (6): 1255—1258.
22. Westaby S., Johnsson P., Parry A.J. et al.Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann. Thorac. Surg. 1996; 61 (1): 88—92.
23. Gazzolo D., Vinesi P., Marinoni E. et al.S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin. Chem. 2000; 46 (7): 998—1000.
24. Gazzolo D., di Iorio R., Marinoni E. et al.S100B Protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit. Care Med. 2002; 30 (6): 1356—1360.
25. Nagdyman N., Komen W., Ko H. K. et al.Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr. Res. 2001; 49 (4): 502—506.
26. Gazzolo D., Marinoni E., di Iorio R. et al.Circulating S100B protein is increased in intrauterine growth retarded fetuses. Pediatr. Res. 2002; 51 (2): 215—219.
27. Gazzolo D., Bruschettini M., Lituania M. et al.Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin. Chem. 2001; 47 (10): 1836—1838.
28. Gazzolo D., Masetti P., Vinesi P. et al.S100B blood levels correlate with rewarming time and cerebral Doppler in pediatric open heart surgery. J. Card. Surg. 2002; 17 (4): 279-284.
29. Gazzolo D., Masetti P., Meli M. et al.Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracor-poreal membrane oxygenation. Acta Paediatr. 2002; 91 (2): 218—221.
30. PawluskiJ. L., Galea L. A., Brain U. et al.Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 2009; 124 (4): e662—e670.
31. Gazzolo D., Visser G. H. A., Lituania M. et al.S100B protein cord blood levels and fetal behavioural states of development: a study in normal and small for dates fetuses. J. Matern. Fetal Neonatal Med. 2002; 11 (6): 378—384.
32. Tramontina F., Leite M. C., Gongalves D. et al.High glutamate decreases S-100B secretion by a mechanism dependent on the glutamate transporter. Neurochem. Res. 2006; 31 (6): 815—820.
33. Jonsson H., Johnsson P., Hoglund P. et al.Elimination of S100B and renal function after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2000; 14 (6): 698—701.
34. Gazzolo D., Abella R., Marinoni E. et al.New markers of neonatal neurology. J. Matern. Fetal Neonatal Med. 2009; 22 (Suppl 3): 57—61.
35. Friel L. A., Romero R., Edwin S. et al.The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra-amniotic infection/inflammation and preterm labor with intact or ruptured membranes. J. Perinat. Med. 2007; 35 (5): 385—393.
36. Sen J., Belli A.S100B in neuropathologic states: the CRP of the brain? J. Neurosci. Res. 2007; 85 (7): 1373—1380.
37. Anderson R. E., Hansson L. O., Liska J. et al.The effect of cardiotomy suction on the brain injury marker S100B after cardiopulmonary bypass. Ann. Thorac. Surg. 2000; 69 (3): 847—850.
38. Carrier M., Denault A., Lavoie J., Perrault L. P.Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Ann. Thorac. Surg. 2006; 82 (1): 51—55.
39. Wojtczak-Soska K., Lelonek M.S-100B protein: An early prognostic marker after cardiac arrest. Cardiol. J. 2010; 17 (5): 532—536.
40. B<3ttiger B. W., Mobes S., Glatzer R. et al.Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103 (22): 2694—2698.
41. Rosen H., Sunnerhagen K. S., Herlitz J. et al.Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001; 49 (2): 183—191.
42. Ralay Ranaivo H., Craft J. M., Hu W. et al.Glia as a therapeutic target: selective suppression of human amyloid-/^-induced upregulation of brain proinflammatory cytokine production attenuates neurodegenera-tion. J. Neurosci. 2006; 26 (2): 662—670.
43. Nguyen D. N., Spapen H., Su F. et al.Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 2006; 34 (7): 1967—1974.
44. Spapen H., Nguyen D. N., TroubleynJ. et al.Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock. Crit. Care 2010; 14 (2): R54.
45. Lipcsey M., Olovsson M., Larsson E. et al.The brain is a source of S100B increase during endotoxemia in the pig. Anesth. Analg. 2010; 110 (1): 174—180.
46. Piazza O., Cotena S., De Robertis E. et al.Sepsis associated encephalopa-thy studied by MRI and cerebral spinal fluid S100B measurement. Neurochem. Res. 2009; 34 (7): 1289—1292.
47. Siami S., Annane D., Sharshar T.The encephalopathy in sepsis. Crit. Care Clin. 2008; 24 (1): 67—82, viii.
48. Hamed S. A., Hamed E. A., Zakary M. M.Oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurol. 2009; 9: 51.
49. Hamed S. A., Hamed E. A., Abdella M. M.Septic encephalopathy: relationship to serum and cerebrospinal fluid levels of adhesion molecules, lipid peroxides and S-100B protein. Neuropediatrics 2009; 40 (2): 66—72.
50. Gazzolo D., Grutzfeld D., Michetti F. et al.Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin. Chem. 2004; 50 (5): 941—944.
51. Кармен Н. Б., Мороз В. В., Маевский Е. И.Механизмы вторичного повреждения нейронов при тяжелой черепно-мозговой травме (часть 1). Общая реаниматология 2011; VII (4): 56—59.
52. Ельский В. Н., Зяблицев С. В., Якубенко Е. Д. и соавт.Перекисное окисление липидов при черепно-мозговой травме (экспериментальное исследование). Общая реаниматология 2009; V (4): 24—30.
53. Ohtaki N., Kamitani W., Watanabe Y. et al.Down regulation of an astro-cyte-derived inflammatory protein, S-100B, reduces vascular inflammatory responses in brains persistently infected with Borna disease virus. J. Virol. 2007; 81 (11): 5940—5948.
54. dos Santos A. Q., Nardin P., Funchal C. et al.Resveratrol increases glu-tamate uptake and glutamine synthetase activity in C6 glioma cells. Arch. Biochem. Biophys. 2006; 453 (2): 161 — 167.
Рецензия
Для цитирования:
Белобородова Н.В., Дмитриева И.Б., Черневская Е.А. Диагностическая значимость белка S100B при критических состояниях . Общая реаниматология. 2011;7(6):72. https://doi.org/10.15360/1813-9779-2011-6-72
For citation:
Beloborodova N.V., Dmitriyeva I.B., Chernevskaya E.A. Diagnostic Value of S100B Protein in Critical Conditions . General Reanimatology. 2011;7(6):72. (In Russ.) https://doi.org/10.15360/1813-9779-2011-6-72